OTCPK:AGHC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. More Details


Snowflake Analysis

Weak fundamentals or lack of information.


Similar Companies

Share Price & News

How has Aeon Global Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AGHC's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-27.7%

AGHC

-4.9%

US Healthcare

-2.4%

US Market


1 Year Return

-74.6%

AGHC

17.9%

US Healthcare

12.0%

US Market

Return vs Industry: AGHC underperformed the US Healthcare industry which returned 17.2% over the past year.

Return vs Market: AGHC underperformed the US Market which returned 10.9% over the past year.


Shareholder returns

AGHCIndustryMarket
7 Day-27.7%-4.9%-2.4%
30 Day-48.6%-6.1%-6.5%
90 Day-29.1%-0.8%8.4%
1 Year-74.6%-74.6%19.5%17.9%14.5%12.0%
3 Year-97.7%-97.7%20.8%15.5%34.8%25.8%
5 Yearn/a46.3%35.9%82.1%61.6%

Price Volatility Vs. Market

How volatile is Aeon Global Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Aeon Global Health undervalued compared to its fair value and its price relative to the market?


Share Price vs. Fair Value

Below Fair Value: AGHC ($0.05) is trading above our estimate of fair value ($0)

Significantly Below Fair Value: AGHC is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AGHC is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: AGHC is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AGHC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AGHC has negative assets, so we can't compare its PB Ratio to the US Healthcare industry average.


Next Steps

Future Growth

How is Aeon Global Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aeon Global Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of AGHC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Aeon Global Health's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Aeon Global Health performed over the past 5 years?

0.3%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: AGHC is currently unprofitable.

Growing Profit Margin: AGHC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if AGHC's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare AGHC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AGHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: AGHC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is Aeon Global Health's financial position?


Financial Position Analysis

Short Term Liabilities: AGHC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: AGHC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: AGHC has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: AGHC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if AGHC has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AGHC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Aeon Global Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AGHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AGHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AGHC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AGHC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AGHC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.7yrs

Average board tenure


CEO

Sonny Roshan (56 yo)

4.08yrs

Tenure

US$359,735

Compensation

Mr. Hanif A. Roshan, also known as Sonny, Founded AEON Global Health Corp. in 2010 and has been its Chief Executive Officer and interim Principal Accounting Officer since August 7, 2016 and December 06, 20 ...


CEO Compensation Analysis

Compensation vs Market: Sonny's total compensation ($USD0.00) is below average for companies of similar size in the US market ($USD606.89K).

Compensation vs Earnings: Sonny's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Hanif Roshan
Founder4.08yrsUS$359.74k17.71%
$ 62.2k
James Flowers
Member of Scientific Advisory Boardno datano datano data
Charles Lucas
Independent Director7.75yrsUS$8.03kno data
Varinder Rathore
Independent Director4.67yrsUS$5.79kno data
Mustafa Chagani
Independent Director4.67yrsUS$5.79kno data
Ruben Alexander
Member of Scientific Advisory Boardno datano datano data
Michael Bodri
Member of Scientific Advisory Boardno datano datano data
Nael Mccarty
Member of Scientific Advisory Boardno datano datano data
Geralyn Datz
Member of Scientific Advisory Boardno datano datano data
Miguel De La Garza
Member of Scientific Advisory Boardno datano datano data
Naomi Florea
Member of Scientific Advisory Boardno datano datano data
Aijaz Khowaja
Member of Scientific Advisory Boardno datano datano data

4.7yrs

Average Tenure

55.5yo

Average Age

Experienced Board: AGHC's board of directors are considered experienced (4.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Aeon Global Health Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Aeon Global Health Corp.
  • Ticker: AGHC
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$351.489k
  • Shares outstanding: 9.92m
  • Website: https://www.aeonglobalhealth.com

Number of Employees


Location

  • Aeon Global Health Corp.
  • 2225 Centennial Drive
  • Gainesville
  • Georgia
  • 30504
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AGHCOTCPK (Pink Sheets LLC)YesCommon StockUSUSDApr 2004

Biography

Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/26 07:15
End of Day Share Price2020/09/25 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.